JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.03% |
| 2 | Healthcare | 12.52% |
| 3 | Financials | 10.5% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXON
1901
Axon Enterprise
AXON
$48.7B
| $12.4M | ﹤0.01% |
133,463
+1,341
| +1% | +$142K |
|
1902
Vanguard FTSE Pacific ETF
VPL
$8.58B
| $12.4M | ﹤0.01% |
195,852
-10,050
| -5% | -$687K |
|
|
KFYP
1903
PUT
DELISTED
KraneShares CICC China Leaders 100 Index ETF
KFYP
| $12.4M | ﹤0.01% |
379,400
-1,100,500
| -74% | -$29.2M |
|
1904
PUT
Logitech
LOGI
$14.8B
| $12.4M | ﹤0.01% |
238,200
+144,500
| +154% | +$8.9M |
|
|
AAT
1905
American Assets Trust
AAT
$1.39B
| $12.3M | ﹤0.01% |
415,440
-55,537
| -12% | -$1.86M |
|
1906
Penumbra
PEN
$12.9B
| $12.3M | ﹤0.01% |
99,082
+19,657
| +25% | +$3.12M |
|
|
MRC
1907
DELISTED
MRC Global
MRC
| $12.3M | ﹤0.01% |
1,237,313
+43,926
| +4% | +$487K |
|
1908
Customers Bancorp
CUBI
$2.8B
| $12.3M | ﹤0.01% |
361,943
+544
| +0.2% | +$22.1K |
|
|
SEE
1909
DELISTED
Sealed Air
SEE
| $12.3M | ﹤0.01% |
212,530
-34,838
| -14% | -$2.2M |
|
1910
CALL
Alnylam Pharmaceuticals
ALNY
$30B
| $12.3M | ﹤0.01% |
84,100
+12,800
| +18% | +$1.82M |
|
1911
PUT
Monster Beverage
MNST
$90.1B
| $12.2M | ﹤0.01% |
527,600
+394,000
| +295% | +$8.57M |
|
1912
CALL
DuPont de Nemours
DD
$19.5B
| $12.2M | ﹤0.01% |
175,028
-999,976
| -85% | -$81.8M |
|
1913
Blackbaud
BLKB
$2.03B
| $12.2M | ﹤0.01% |
209,437
+66,196
| +46% | +$3.85M |
|
1914
Allegion
ALLE
$14.1B
| $12.2M | ﹤0.01% |
124,222
-1,030,746
| -89% | -$112M |
|
1915
CALL
Freeport-McMoran
FCX
$96.9B
| $12.2M | ﹤0.01% |
415,500
-520,800
| -56% | -$20.8M |
|
1916
PUT
Danaher
DHR
$145B
| $12.1M | ﹤0.01% |
53,918
+6,542
| +14% | +$1.51M |
|
1917
National Health Investors
NHI
$3.47B
| $12.1M | ﹤0.01% |
199,668
-61,600
| -24% | -$3.51M |
|
|
SAVE
1918
DELISTED
Spirit Airlines, Inc.
SAVE
| $12M | ﹤0.01% |
504,647
+399,611
| +380% | +$8.86M |
|
1919
Itron
ITRI
$4.49B
| $11.9M | ﹤0.01% |
241,705
-31,543
| -12% | -$1.56M |
|
1920
CALL
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$6.11B
| $11.9M | ﹤0.01% |
100,000
+37,500
| +60% | +$1.11M |
|
1921
Shutterstock
SSTK
$208M
| $11.9M | ﹤0.01% |
208,421
+88,896
| +74% | +$5.95M |
|
1922
Minerals Technologies
MTX
$2.25B
| $11.9M | ﹤0.01% |
194,279
+10,159
| +6% | +$649K |
|
1923
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.6B
| $11.9M | ﹤0.01% |
214,934
+72,861
| +51% | +$4.21M |
|
1924
Trex
TREX
$5.05B
| $11.9M | ﹤0.01% |
218,355
-612,859
| -74% | -$37M |
|
1925
Kymera Therapeutics
KYMR
$9.48B
| $11.9M | ﹤0.01% |
603,378
+439,903
| +269% | +$10.3M |
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.